γ-Secretase inhibitors and Alzheimer’s disease

This publication has 67 references indexed in Scilit:

• Nasal Vaccination withβ-Amyloid Peptide for the Treatment of Alzheimer's Disease
  DNA and Cell Biology, 2001
• New Frontiers in Alzheimer's Disease Genetics
  Neuron, 2001
• A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease
  Neurobiology of Disease, 2001
• Treatment with controlled-release lovastatin decreases serum concentrations of human β-amyloid (Aβ) peptide
  International Journal of Neuropsychopharmacology, 2001
• Presenilins as therapeutic targets for the treatment of Alzheimer's disease
  Trends in Molecular Medicine, 2001
• Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice
  Published by Elsevier ,2001
• Potential Treatment Opportunities for Alzheimer's Disease Through Inhibition of Secretases and Aβ Immunization
  Journal of Molecular Neuroscience, 2001
• Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
  Nature Medicine, 2000
• Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
  Nature, 1999
• Alzheimer's Disease: The Amyloid Cascade Hypothesis
  Science, 1992